Predictive Technology Group, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021
May 17, 2021 at 04:58 pm EDT
Share
Predictive Technology Group, Inc. announced earnings results for the third quarter ended March 31, 2021. For the third quarter, the company announced sales was USD 6.893 million compared to USD 5.723 million a year ago. Operating loss was USD 3.233 million compared to USD 11.723 million a year ago. Net loss was USD 7.387 million compared to USD 13.700 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.05 a year ago. For the nine months, sales was USD 16.052 million compared to USD 21.319 million a year ago. Operating loss was USD 24.650 million compared to USD 38.343 million a year ago. Net loss was USD 29.952 million compared to USD 47.568 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.16 a year ago.
Predictive Technology Group, Inc. is a life science company. The Company, through its subsidiaries, is focused on specific points of the care continuum, including detection, prevention and treatment. Predictive Analytics, Predictive Laboratories, and Predictive Biotech each bring critical solutions to personalized patient care by leveraging its research, genomics, genetic library and expertise in developing bioscience solutions. Predictive Analytics is the repository for its genetic library. Predictive Biotech provides regenerative medicine. Its products are derived from tissue sources rich in properties that support the bodyâs natural ability to heal itself. All products are safely, ethically and minimally processed to deliver allografts that preserve the naturally occurring characteristics and factors of the donor tissue. Its research and use of processing methods has propelled its placental-derived and Whartonâs Jelly umbilical cord-derived products to new heights.